Skip to main content
. Author manuscript; available in PMC: 2021 Jan 1.
Published in final edited form as: Am J Perinatol. 2019 Sep 6;37(1):59–65. doi: 10.1055/s-0039-1696719

Table 2.

Marijuana and other substance use, 2012–2015

Substance Use Measure 2012 n=566 (%) 2013 n=599 (%) 2014 n=630 (%) 2015 n=597 (%) P P trend
Self-reported marijuana use 16 (2.8) 22 (3.7) 45 (7.1) 29 (4.9) 0.002 0.0139
Meconium sample at delivery positive for marijuana 6 (1.1) 0 (0.0) 4 (0.6) 8 (1.3) 0.043 0.3319
Urine sample at first prenatal visit positive for marijuana 3 (0.5) 9 (1.5) 13 (2.1) 5 (0.8) 0.076 0.4828
Urine sample at delivery positive for marijuana 2 (8.7) 1 (5.3) 14 (31.8) 2 (13.3) 0.045 0.0523
Any marijuana by self-report or biological sampling 21 (3.7) 28 (4.7) 54 (8.6) 35 (5.9) 0.002 0.0158
Meconium or urine sample positive for opioids 3 (0.5) 3 (0.5) 7 (1.1) 2 (0.3) 0.331 0.9792
Meconium or urine sample positive for illegal drugs 4 (0.7) 5 (0.8) 8 (1.3) 6 (1.0) 0.77 0.4593
Any illegal drugs or opioids by self-report or biological sampling 11 (1.9) 9 (1.5) 22 (3.5) 10 (1.7) 0.064 0.6432
Self-reported tobacco use 47 (8.3) 49 (8.2) 57 (9.0) 46 (7.7) 0.862 0.8587
Self-reported alcohol use 5 (0.9) 3 (0.5) 13 (2.1) 6 (1.0) 0.059 0.3098

P values from both overall chi-square and additionally a test of trend.